search
Back to results

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG (PACES)

Primary Purpose

Atrial Fibrillation, Stroke, Bleeding

Status
Recruiting
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Antiplatelet-only strategy
Oral Anticoagulant plus background antiplatelet therapy
Sponsored by
Icahn School of Medicine at Mount Sinai
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Atrial Fibrillation focused on measuring Anticoagulation, Antiplatelet Therapy, Post Operative Atrial Fibrillation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients of age ≥18 years who undergo isolated CABG for coronary artery disease
  • POAF that persists for >60 minutes or is recurrent (more than one episode) within 7 days after the index CABG surgery

Exclusion Criteria:

  • Clinical history of either permanent, persistent or paroxysmal atrial fibrillation
  • Any pre-existing clinical indication for long-term OAC
  • Any absolute contraindication to OAC

  • Planned use of post-operative dual antiplatelet therapy (DAPT)

    a. This includes, but is not limited to, patients with recent PCI with drug-eluting or bare-metal stent.

  • Cardiogenic shock

  • Major perioperative complication* occurring between CABG and randomization

    a. Including stroke, TIA, MI, major bleeding (BARC type 4 bleeding), severe sepsis, renal failure requiring dialysis, or need for reoperation due to bleeding (e.g. pericardial tamponade).

  • Concomitant left atrial appendage closure during CABG
  • Concomitant valve surgery during CABG (including aortic, mitral, tricuspid or pulmonary)
  • Concomitant or prior surgery for AF during CABG
  • Closure of an atrial septal defect or of a patent foramen ovale during CABG
  • Liver cirrhosis or Child-Pugh Class C chronic liver disease
  • Pharmacologic therapy with an investigational drug or device within 30-days prior to randomization or plan to enroll patient in an investigational drug or device trial during participation in this trial
  • Pregnancy at the time of randomization
  • Unable or unwilling to provide inform consent
  • Unable or unwilling to comply with the study treatment and follow-up
  • Existence of underlying disease that limits life expectancy to less than one year

Sites / Locations

  • CHI St. Vincent, ArkansasRecruiting
  • University of Southern CaliforniaRecruiting
  • Cedars-Sinai Medical CenterRecruiting
  • Stanford UniversityRecruiting
  • Medical Center of Aurora
  • Western Connecticut Hospital Systems
  • Yale New HavenRecruiting
  • MedStar Washington Hospital CenterRecruiting
  • Emory UniversityRecruiting
  • Piedmont Healthcare Inc.Recruiting
  • Lutheran Medical CenterRecruiting
  • Indiana UniversityRecruiting
  • Ascension St. VincentRecruiting
  • Ochsner ClinicRecruiting
  • Maine Medical CenterRecruiting
  • University of MarylandRecruiting
  • Johns HopkinsRecruiting
  • Suburban HospitalRecruiting
  • Massachusetts General HospitalRecruiting
  • Brigham and Women's HospitalRecruiting
  • Boston Medical CenterRecruiting
  • Baystate Health
  • University of MichiganRecruiting
  • Mayo Clinic
  • Mid America Health InstituteRecruiting
  • Washington University School of MedicineRecruiting
  • Dartmouth-Hitchcock Medical CenterRecruiting
  • Jersey Shore University Medical CenterRecruiting
  • Montefiore Medical CenterRecruiting
  • Northwell Health SystemRecruiting
  • The Mount Sinai Hospital
  • Columbia University Medical CenterRecruiting
  • Duke UniversityRecruiting
  • East Carolina UniversityRecruiting
  • WakeMed
  • Cleveland Clinic FoundationRecruiting
  • Ohio State University Medical CenterRecruiting
  • Ascension St. JohnRecruiting
  • University of Pittsburgh Medical Center
  • University of PennsylvaniaRecruiting
  • Allegheny Health NetworkRecruiting
  • Baylor College of MedicineRecruiting
  • Baylor Research InstituteRecruiting
  • Intermountain CV ResearchRecruiting
  • University of UtahRecruiting
  • University of VermontRecruiting
  • University of Virginia Health SystemRecruiting
  • Inova Health
  • West Virginia UniversityRecruiting
  • University of WisconsinRecruiting
  • University of Alberta HospitalRecruiting
  • London Health Sciences CentreRecruiting
  • University of Ottawa Heart Institute
  • Sunnybrook HospitalRecruiting
  • Toronto General Hospital
  • Montreal Heart InstituteRecruiting
  • Centre Hospitalier de l'Université de MontréalRecruiting
  • Hôpital du Sacré-Cœur de Montréal
  • Hôpital LavalRecruiting
  • University Heart Center Hamburg
  • Heart Center LeipzigRecruiting
  • University Medical Center Göttingen
  • University Medical Center JenaRecruiting
  • Clinic Bad Neustadt - Medical Center for Heart and Vascular Diseases
  • HDZ-NRW Bad Oeynhausen
  • Charité Berlin - Benjamin Franklin Campus
  • Charité Berlin - Rudolf Virchow Campus
  • German Heart Center BerlinRecruiting
  • University Hospital BonnRecruiting
  • Medical Center Braunschweig
  • University Medical Center Frankfurt
  • Heart Center, University of Freiburg
  • University Medical Center Heidelberg
  • University Medical Center Schleswig-Holstein Kiel
  • University Medical Center Schleswig-Holstein Lübeck
  • German Heart Center Munich
  • Medical Center of the Ludwig-Maximilians-University Munich
  • University Hospitals Bristol NHS Foundation TrustRecruiting
  • Hull University Teaching Hospitals NHS TrustRecruiting
  • South Tees Hospitals NHS Foundation TrustRecruiting
  • Nottingham University Hospitals NHS TrustRecruiting
  • Oxford University Hospitals NHS Foundation TrustRecruiting
  • Sheffield Teaching Hospitals NHS Foundation TrustRecruiting
  • University Hospitals Sussex NHS Foundation TrustRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Antiplatelet Therapy

Oral Anticoagulant

Arm Description

Antiplatelet-only strategy

OAC-based strategy

Outcomes

Primary Outcome Measures

Composite of death, ischemic stroke, TIA, MI, systemic arterial thromboembolism or venous thromboembolism (DVT and/or PE)
Composite score of death, ischemic stroke, transient ischemic attack (TIA), myocardial infarction (MI), systemic arterial thromboembolism or venous thromboembolism (deep venous thrombosis and/or pulmonary embolism). Composite score calculated by number of events.
Any BARC type 3 or 5
The Bleeding Academic Research Consortium (BARC) - any type 3 or 5 bleeding thrombosis and/or pulmonary. Type 3: a. Overt bleeding plus hemoglobin drop of 3 to < 5 g/dL (provided hemoglobin drop is related to bleed); transfusion with overt bleeding b. Overt bleeding plus hemoglobin drop < 5 g/dL (provided hemoglobin drop is related to bleed); cardiac tamponade; bleeding requiring surgical intervention for control; bleeding requiring IV vasoactive agents c. Intracranial hemorrhage confirmed by autopsy, imaging, or lumbar puncture; intraocular bleed compromising vision. type 5: a. Probable fatal bleeding b. Definite fatal bleeding (overt or autopsy or imaging confirmation)

Secondary Outcome Measures

Net clinical benefit (NCB)
Defined as the integration of the trial's primary effectiveness and safety endpoint to capture overall risk and benefit of anticoagulation. NCB will be assessed as a two-dimensional outcome with the observed NCB plotted versus effectiveness and safety, and a curve drawn. the confidence intervals will be compared to this curve.
Number of participants with Ischemic Stroke event
Number of participants with TIA event
Number of participants with MI event
Number of participants with systematic arterial thromboembolism event
Number of participants with venous thromboembolism event
Number of cardiovascular mortalities
Number of non-cardiovascular mortalities
The incidence of BARC 2 bleeding at 90 after randomization
BARC Type 2: Any clinically overt sign of hemorrhage that "is actionable" and requires diagnostic studies, hospitalization, or treatment by a health care professional
The incidence of BARC 2 bleeding at 180 days after randomization
BARC Type 2: Any clinically overt sign of hemorrhage that "is actionable" and requires diagnostic studies, hospitalization, or treatment by a health care professional
Number of cardiac arrhythmias
Number of cardiac arrhythmias including recurrent symptomatic or asymptomatic AF requiring medical attention

Full Information

First Posted
August 2, 2019
Last Updated
May 19, 2023
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
National Heart, Lung, and Blood Institute (NHLBI), Vanderbilt University Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04045665
Brief Title
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Acronym
PACES
Official Title
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 13, 2019 (Actual)
Primary Completion Date
June 30, 2025 (Anticipated)
Study Completion Date
June 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
National Heart, Lung, and Blood Institute (NHLBI), Vanderbilt University Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery. All patients with a qualifying POAF event, who decline randomization, will be offered the option of enrollment in a parallel registry that captures their baseline risk profile and their treatment strategy in terms of anticoagulants or antiplatelets received. These patients will also be asked to fill out a brief decliner survey.
Detailed Description
This is a prospective, multicenter, open-label, randomized trial comparing OAC with no OAC (1:1 ratio) in patients who develop new-onset POAF after CABG. The primary effectiveness endpoint is the composite of death, ischemic stroke, transient ischemic attack (TIA), myocardial infarction (MI), systemic arterial thromboembolism or venous thromboembolism (VTE) at 90 days after randomization. The primary safety endpoint is BARC (Bleeding Academic Research Consortium) grade 3 or 5 bleeding at 90 days after randomization. The overall intent is to evaluate the trade-off in prevention of thromboembolic events versus an increase in bleeding. Patients will be randomly assigned to the following treatment strategies: OAC-based strategy (experimental arm): OAC with vitamin K antagonist (VKA) with international normalized ratio (INR) target 2-3 or any approved direct oral anticoagulant (apixaban, rivaroxaban, edoxaban or dabigatran) in addition to background antiplatelet therapy with aspirin 75-325mg once-daily or a P2Y12-inhibitor (clopidogrel or ticagrelor) Antiplatelet-only strategy (control arm): single antiplatelet therapy with aspirin 75-325mg once-daily or a P2Y12-inhibitor (clopidogrel or ticagrelor) The protocol-specified duration of anticoagulation is 90 days. Patients, who are randomized to the control arm and develop recurrent AF after 30 days, may be crossed-over to an OAC. Accrual is expected to take 60 months. Study follow-up visits will be performed at 90 days and phone follow-up at days 30, 60, and 180 days. Data for patients enrolled in the registry will be ascertained from the local clinical site via a review of medical records. The baseline risk profile of registry patients (i.e., patients eligible but unwilling to be randomized) will be analyzed and compared to that of patients randomized in the trial. The usage of anticoagulant and antiplatelet therapies in the registry population overall and baseline CHA2DS2-VASC ischemic stroke risk score will also be determined. Up to 500 patients will also be offered the option to participate in a digital health substudy which includes a wearable heart rhythm monitor device for 30 days post discharge.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation, Stroke, Bleeding
Keywords
Anticoagulation, Antiplatelet Therapy, Post Operative Atrial Fibrillation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Model Description
This is a multicenter randomized clinical trial comparing OAC to no-OAC in addition to concomitant antiplatelet therapy in 3,200 eligible patients who develop POAF after isolated CABG. The trial will be conducted by the Cardiothoracic Surgical Trials Network (CTSN), the German Society for Thoracic and Cardiovascular Surgery (DGTHG) and other European sites, the United Kingdom and Brazil..
Masking
None (Open Label)
Allocation
Randomized
Enrollment
3200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Antiplatelet Therapy
Arm Type
Active Comparator
Arm Description
Antiplatelet-only strategy
Arm Title
Oral Anticoagulant
Arm Type
Active Comparator
Arm Description
OAC-based strategy
Intervention Type
Drug
Intervention Name(s)
Antiplatelet-only strategy
Intervention Description
Aspirin 75-325 mg once-daily or a P2Y12-inhibitor (clopidogrel or ticagrelor)
Intervention Type
Drug
Intervention Name(s)
Oral Anticoagulant plus background antiplatelet therapy
Intervention Description
OAC with vitamin K antagonist (VKA) with international normalized ratio (INR) target 2-3 or any approved direct oral anticoagulant OR apixaban, rivaroxaban, edoxaban or dabigatran) in addition to background antiplatelet therapy with aspirin 75-325mg once-daily or a P2Y12-inhibitor (clopidogrel or ticagrelor)
Primary Outcome Measure Information:
Title
Composite of death, ischemic stroke, TIA, MI, systemic arterial thromboembolism or venous thromboembolism (DVT and/or PE)
Description
Composite score of death, ischemic stroke, transient ischemic attack (TIA), myocardial infarction (MI), systemic arterial thromboembolism or venous thromboembolism (deep venous thrombosis and/or pulmonary embolism). Composite score calculated by number of events.
Time Frame
up to 180 days after randomization
Title
Any BARC type 3 or 5
Description
The Bleeding Academic Research Consortium (BARC) - any type 3 or 5 bleeding thrombosis and/or pulmonary. Type 3: a. Overt bleeding plus hemoglobin drop of 3 to < 5 g/dL (provided hemoglobin drop is related to bleed); transfusion with overt bleeding b. Overt bleeding plus hemoglobin drop < 5 g/dL (provided hemoglobin drop is related to bleed); cardiac tamponade; bleeding requiring surgical intervention for control; bleeding requiring IV vasoactive agents c. Intracranial hemorrhage confirmed by autopsy, imaging, or lumbar puncture; intraocular bleed compromising vision. type 5: a. Probable fatal bleeding b. Definite fatal bleeding (overt or autopsy or imaging confirmation)
Time Frame
90 days after randomization
Secondary Outcome Measure Information:
Title
Net clinical benefit (NCB)
Description
Defined as the integration of the trial's primary effectiveness and safety endpoint to capture overall risk and benefit of anticoagulation. NCB will be assessed as a two-dimensional outcome with the observed NCB plotted versus effectiveness and safety, and a curve drawn. the confidence intervals will be compared to this curve.
Time Frame
90 days after randomization
Title
Number of participants with Ischemic Stroke event
Time Frame
180 days after randomization
Title
Number of participants with TIA event
Time Frame
180 days after randomization
Title
Number of participants with MI event
Time Frame
180 days after randomization
Title
Number of participants with systematic arterial thromboembolism event
Time Frame
180 days after randomization
Title
Number of participants with venous thromboembolism event
Time Frame
180 days after randomization
Title
Number of cardiovascular mortalities
Time Frame
up to 180 days after randomization
Title
Number of non-cardiovascular mortalities
Time Frame
up to 180 days after randomization
Title
The incidence of BARC 2 bleeding at 90 after randomization
Description
BARC Type 2: Any clinically overt sign of hemorrhage that "is actionable" and requires diagnostic studies, hospitalization, or treatment by a health care professional
Time Frame
90 days after randomization
Title
The incidence of BARC 2 bleeding at 180 days after randomization
Description
BARC Type 2: Any clinically overt sign of hemorrhage that "is actionable" and requires diagnostic studies, hospitalization, or treatment by a health care professional
Time Frame
180 days after randomization
Title
Number of cardiac arrhythmias
Description
Number of cardiac arrhythmias including recurrent symptomatic or asymptomatic AF requiring medical attention
Time Frame
180 days after randomization

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients of age ≥18 years who undergo isolated CABG for coronary artery disease POAF that persists for >60 minutes or is recurrent (more than one episode) within 7 days after the index CABG surgery Exclusion Criteria: Clinical history of either permanent, persistent or paroxysmal atrial fibrillation Any pre-existing clinical indication for long-term OAC Any absolute contraindication to OAC Planned use of post-operative dual antiplatelet therapy (DAPT) a. This includes, but is not limited to, patients with recent PCI with drug-eluting or bare-metal stent. Cardiogenic shock Major perioperative complication* occurring between CABG and randomization a. including, but not limited to, stroke, TIA, MI, major bleeding (BARC type 4 bleeding), severe sepsis, renal failure requiring dialysis, or need for reoperation due to bleeding (e.g. pericardial tamponade). Concomitant left atrial appendage closure during CABG Concomitant valve surgery during CABG or prior valve surgery (including aortic, mitral, tricuspid or pulmonary) Concomitant mitral valve annuloplasty during CABG Concomitant carotid artery endarterectomy during CABG Concomitant aortic root replacement during CABG Concomitant surgery for AF during CABG Liver cirrhosis or Child-Pugh Class C chronic liver disease Pharmacologic therapy with an investigational drug or device within 30-days prior to randomization or plan to enroll patient in an investigational drug or device trial during participation in this trial Pregnancy at the time of randomization Unable or unwilling to provide inform consent Unable or unwilling to comply with the study treatment and follow-up Existence of underlying disease that limits life expectancy to less than one year
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ellen Moquete, RN
Phone
212-659-9651
Email
ellen.moquete@mountsinai.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Annetine C Gelijns, PhD
Organizational Affiliation
Icahn School of Medicine at Mount Sinai
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Marc Gillinov, MD
Organizational Affiliation
The Cleveland Clinic
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
John Alexander, MD
Organizational Affiliation
Duke University
Official's Role
Study Director
Facility Information:
Facility Name
CHI St. Vincent, Arkansas
City
Little Rock
State/Province
Arkansas
ZIP/Postal Code
72205
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lynn Bass
Email
lynn.bass@commonspirit.org
First Name & Middle Initial & Last Name & Degree
Thurston Bauer
Facility Name
University of Southern California
City
Los Angeles
State/Province
California
ZIP/Postal Code
90033
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ed Lozano
Email
edwardlo@med.usc.edu
First Name & Middle Initial & Last Name & Degree
Vaughn Starnes, MD
Facility Name
Cedars-Sinai Medical Center
City
Los Angeles
State/Province
California
ZIP/Postal Code
90048
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Achille Peiris
Email
Achille.Peiris@cshs.org
First Name & Middle Initial & Last Name & Degree
Joanna Chikwe, MD
Facility Name
Stanford University
City
Stanford
State/Province
California
ZIP/Postal Code
94305
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tiffany Flores
Email
tflores2@stanford.edu
First Name & Middle Initial & Last Name & Degree
Jack Boyd
Facility Name
Medical Center of Aurora
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80012
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Western Connecticut Hospital Systems
City
Danbury
State/Province
Connecticut
ZIP/Postal Code
06810
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Yale New Haven
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06520-8039
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marianne McCarthy
Email
marianne.mccarthy@yale.edu
First Name & Middle Initial & Last Name & Degree
Arnar Geirsson
Facility Name
MedStar Washington Hospital Center
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20010
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katharine Mahoney
Email
Katharine.E.Mahoney@medstar.net
First Name & Middle Initial & Last Name & Degree
Christian Shults, MD
Facility Name
Emory University
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30308
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mary McBride
Email
mary.mcbride@emory.edu
First Name & Middle Initial & Last Name & Degree
Michael Halkos
Facility Name
Piedmont Healthcare Inc.
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30309
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amy Autry-Bush
Email
Amy.Autry-Bush@piedmont.org
First Name & Middle Initial & Last Name & Degree
Vinod Thourani, MD
Facility Name
Lutheran Medical Center
City
Fort Wayne
State/Province
Indiana
ZIP/Postal Code
46825
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sharon Eichman
Email
SEichman@Lutheran-Hosp.com
First Name & Middle Initial & Last Name & Degree
Vincent Scavo
Facility Name
Indiana University
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46202
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Srdjan Kurbalija
Email
skurbalija@iuhealth.org
First Name & Middle Initial & Last Name & Degree
Joel Corvera, MD
Facility Name
Ascension St. Vincent
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46260
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jena Stanley
Phone
317-338-6450
Email
jena.stanley@ascension.org
First Name & Middle Initial & Last Name & Degree
David Heimansohn
Facility Name
Ochsner Clinic
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70121
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nicolle Scholl
Email
nicolle.scholl@ochsner.org
First Name & Middle Initial & Last Name & Degree
P. Eugene Parrino
Facility Name
Maine Medical Center
City
Portland
State/Province
Maine
ZIP/Postal Code
04102
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Betsey Gallant
Email
betsey.gallant@mainehealth.org
First Name & Middle Initial & Last Name & Degree
Robert Kramer
Facility Name
University of Maryland
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21201
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Manal Al-Suqi
Email
MaAl-Suqi@som.umaryland.edu
First Name & Middle Initial & Last Name & Degree
Mehrdad Ghoreishi, MD
Facility Name
Johns Hopkins
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21287
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zyriah Robinson
Email
zyriah.robinson@jhmi.edu
First Name & Middle Initial & Last Name & Degree
James Gammie, MD
First Name & Middle Initial & Last Name & Degree
Thomas Matthew, MD
Facility Name
Suburban Hospital
City
Bethesda
State/Province
Maryland
ZIP/Postal Code
20814
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tara Reddy
Email
treddy4@jh.edu
First Name & Middle Initial & Last Name & Degree
Thomas Matthew
Facility Name
Massachusetts General Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jenna Barnes
Email
JBARNES21@mgh.harvard.edu
First Name & Middle Initial & Last Name & Degree
David D'Alessandro
Facility Name
Brigham and Women's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mariam Kerolos
Email
mkerolos@bwh.harvard.edu
First Name & Middle Initial & Last Name & Degree
Sary Aranki
Facility Name
Boston Medical Center
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02118
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Darae Ko, MD
Email
daraeko@bu.edu
First Name & Middle Initial & Last Name & Degree
Darae Ko, MD
Facility Name
Baystate Health
City
Springfield
State/Province
Massachusetts
ZIP/Postal Code
01199
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
University of Michigan
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48109
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
China Green
Email
chjgreen@med.umich.edu
First Name & Middle Initial & Last Name & Degree
Jonathan Haft, MD
First Name & Middle Initial & Last Name & Degree
Gorav Ailawadi, MD
Facility Name
Mayo Clinic
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Janell Keehn
Email
keehn.janell@mayo.edu
First Name & Middle Initial & Last Name & Degree
Juan Crestanello
Facility Name
Mid America Health Institute
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64111
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rosann M Gans
Email
rgans@saint-lukes.org
First Name & Middle Initial & Last Name & Degree
Keith Allen
Facility Name
Washington University School of Medicine
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Annette Irving
Email
irvinga@wustl.edu
First Name & Middle Initial & Last Name & Degree
Tsuyoshi Kaneko, MD
Facility Name
Dartmouth-Hitchcock Medical Center
City
Lebanon
State/Province
New Hampshire
ZIP/Postal Code
03766
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Prezley Duncan
Email
Prezley.M.Duncan@hitchcock.org
First Name & Middle Initial & Last Name & Degree
Jock McCullough
Facility Name
Jersey Shore University Medical Center
City
Neptune
State/Province
New Jersey
ZIP/Postal Code
07753
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lynda Argenzio
Email
lynda.argenzio@hmhn.org
First Name & Middle Initial & Last Name & Degree
Joanne Kushnir
Email
Joanne.Kushnir@hmhn.org
First Name & Middle Initial & Last Name & Degree
Kourosh Asgarian, DO
Facility Name
Montefiore Medical Center
City
Bronx
State/Province
New York
ZIP/Postal Code
10467
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Magdalena Mamczur-Madry, RN, BSN, MS, ACRP-CP
Email
mmamczur@montefiore.org
First Name & Middle Initial & Last Name & Degree
Daniel Goldstein, MD
Facility Name
Northwell Health System
City
Great Neck
State/Province
New York
ZIP/Postal Code
11023
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Effe Mihelis
Email
emihelis@northwell.edu
First Name & Middle Initial & Last Name & Degree
Nirav Patel
First Name & Middle Initial & Last Name & Degree
Alexander Iribarne
Facility Name
The Mount Sinai Hospital
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stella Palencia
Email
Stella.Palencia@mountsinai.org
First Name & Middle Initial & Last Name & Degree
John Puskas
Facility Name
Columbia University Medical Center
City
New York
State/Province
New York
ZIP/Postal Code
10032
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amanda Alonso
Email
aa2974@cumc.columbia.edu
First Name & Middle Initial & Last Name & Degree
Michael Argenziano
Facility Name
Duke University
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27710
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kathleen Lane
Email
kathleen.rohrback@duke.edu
First Name & Middle Initial & Last Name & Degree
Brittany Zwischenberger, MD
Facility Name
East Carolina University
City
Greenville
State/Province
North Carolina
ZIP/Postal Code
27858
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eddie Hill
Email
hille19@ecu.edu
First Name & Middle Initial & Last Name & Degree
Shahab A. Akhter
Facility Name
WakeMed
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27610
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rhonda Norton
Email
rnorton@wakemed.org
First Name & Middle Initial & Last Name & Degree
Judson Williams
Facility Name
Cleveland Clinic Foundation
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Denise Kosty-Sweeney
Email
sweened2@ccf.org
First Name & Middle Initial & Last Name & Degree
A Marc Gillinov
Facility Name
Ohio State University Medical Center
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43210
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Neha Mali
Email
Neha.Mali@osumc.edu
First Name & Middle Initial & Last Name & Degree
Bryan Whitson
Facility Name
Ascension St. John
City
Tulsa
State/Province
Oklahoma
ZIP/Postal Code
74103
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jane Bryce
Email
jane.bryce@ascension.org
First Name & Middle Initial & Last Name & Degree
James Neel, MD
Facility Name
University of Pittsburgh Medical Center
City
Hermitage
State/Province
Pennsylvania
ZIP/Postal Code
16148
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Melissa Enlow
Email
enlowms@upmc.edu
First Name & Middle Initial & Last Name & Degree
Robert Kormos
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mary Lou Mayer
Email
MaryLou.Mayer@uphs.upenn.edu
First Name & Middle Initial & Last Name & Degree
Michael Acker
Facility Name
Allegheny Health Network
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15212
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christina Horn
Email
christina.horn@ahn.org
First Name & Middle Initial & Last Name & Degree
M. Scott Halbreiner, MD
Facility Name
Baylor College of Medicine
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Cuneyt Koksoy
Email
CUNEYT.KOKSOY@bcm.edu
First Name & Middle Initial & Last Name & Degree
Todd Rosengart
Facility Name
Baylor Research Institute
City
Plano
State/Province
Texas
ZIP/Postal Code
75093
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kristen Chionh
Email
Kristen.Chionh@BSWHealth.org
First Name & Middle Initial & Last Name & Degree
Michael DiMaio, MD
Facility Name
Intermountain CV Research
City
Murray
State/Province
Utah
ZIP/Postal Code
84107
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Erika Hummel
Email
erika.hummel@imail.org
First Name & Middle Initial & Last Name & Degree
Stephen McKellar, MD
Facility Name
University of Utah
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84112
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ashley Elmer
Email
Ashley.Elmer@hsc.utah.edu
First Name & Middle Initial & Last Name & Degree
Craig Selzman
Facility Name
University of Vermont
City
Burlington
State/Province
Vermont
ZIP/Postal Code
05401
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amy Henderson
Email
Amy.Henderson@uvmhealth.org
First Name & Middle Initial & Last Name & Degree
Marek Polomsky, MD
Facility Name
University of Virginia Health System
City
Charlottesville
State/Province
Virginia
ZIP/Postal Code
22908
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ashley Fox
Email
ATF4C@hscmail.mcc.virginia.edu
First Name & Middle Initial & Last Name & Degree
Kenan Yount, MD
Facility Name
Inova Health
City
Falls Church
State/Province
Virginia
ZIP/Postal Code
22042
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
West Virginia University
City
Morgantown
State/Province
West Virginia
ZIP/Postal Code
26506
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kimberly Quedado
Email
kq10006@wvumedicine.org
First Name & Middle Initial & Last Name & Degree
Vinay Badhwar
Facility Name
University of Wisconsin
City
Madison
State/Province
Wisconsin
ZIP/Postal Code
53792
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Melanie Benito
Email
benito@surgery.wisc.edu
First Name & Middle Initial & Last Name & Degree
Satoru Osaki, MD
Facility Name
University of Alberta Hospital
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G2B7
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Celine Balay
Email
cbalay@ualberta.ca
First Name & Middle Initial & Last Name & Degree
Steven Meyer, MD
Facility Name
London Health Sciences Centre
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 5A5
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stephanie Fox
Email
Stephanie.Fox@lhsc.on.ca
First Name & Middle Initial & Last Name & Degree
Michael Chu
Facility Name
University of Ottawa Heart Institute
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1Y 4W7
Country
Canada
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jacqueline Fortier
Email
JFortier@ottawaheart.ca
First Name & Middle Initial & Last Name & Degree
Marc Ruel
Facility Name
Sunnybrook Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4N 3M5
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Reena Karkhanis
Email
Reena.Karkhanis@sunnybrook.ca
First Name & Middle Initial & Last Name & Degree
Stephen Fremes
Facility Name
Toronto General Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5B 1W8
Country
Canada
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shakira Christie
Email
Shakira.Christie@uhn.ca
First Name & Middle Initial & Last Name & Degree
Terrance Yau
Facility Name
Montreal Heart Institute
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H1T 1C8
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alexandre Bergeron
Email
alexandre.bergeron.Icm@icm-mhi.org
First Name & Middle Initial & Last Name & Degree
Denis Bouchard, MD
Facility Name
Centre Hospitalier de l'Université de Montréal
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H2W 1T8
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Joannie Dionne
Email
joannie.dionne.chum@ssss.gouv.qc.ca
First Name & Middle Initial & Last Name & Degree
Nicolas Noiseux
Facility Name
Hôpital du Sacré-Cœur de Montréal
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H4J 1C5
Country
Canada
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carole Sirois
Email
carole.sirois@crhsc.rtss.qc.ca
First Name & Middle Initial & Last Name & Degree
Hugues Jeanmart
Facility Name
Hôpital Laval
City
Quebec
ZIP/Postal Code
G1V 4G5
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nathalie Gagne
Email
Nathalie.Gagne@criucpq.ulaval.ca
First Name & Middle Initial & Last Name & Degree
Pierre Voisine
Facility Name
University Heart Center Hamburg
City
Berlin
State/Province
Brandenburg
ZIP/Postal Code
11353
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jutta Nogal
Email
j.nogal@uke.de
First Name & Middle Initial & Last Name & Degree
Lennard Conradi, MD
Facility Name
Heart Center Leipzig
City
Berlin
State/Province
Brandenburg
ZIP/Postal Code
13347
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maren Zieger
Email
Maren.Zieger@leipzig-heart.de
First Name & Middle Initial & Last Name & Degree
Michael Borger, MD
Facility Name
University Medical Center Göttingen
City
Göttingen
State/Province
Lower Saxony
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jessika Jordan
Email
jessika.jordan@med.uni-goettingen.de
First Name & Middle Initial & Last Name & Degree
Bernd Danner, MD
Facility Name
University Medical Center Jena
City
Jena
State/Province
Thuringia
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sabine Krauspe
Email
sabine.krauspe@med.uni-jena.de
First Name & Middle Initial & Last Name & Degree
Torsten Doenst, MD
Facility Name
Clinic Bad Neustadt - Medical Center for Heart and Vascular Diseases
City
Bad Neustadt An Der Saale
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katharina Schoenrath
Email
kschoenrath@dhzb.de
First Name & Middle Initial & Last Name & Degree
Anno Diegeler
Facility Name
HDZ-NRW Bad Oeynhausen
City
Bad Oeynhausen
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Heike Windhagen
Email
ch-studien@dhz-nrw.de
First Name & Middle Initial & Last Name & Degree
Kavous Hakim-Meibodi, MD
Facility Name
Charité Berlin - Benjamin Franklin Campus
City
Berlin
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ulf Landmesser, MD
Email
ulf.landmesser@charite.de
First Name & Middle Initial & Last Name & Degree
Ulf Landmesser, MD
Facility Name
Charité Berlin - Rudolf Virchow Campus
City
Berlin
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Burkert Pieske, MD
Email
burkert.pieske@charite.de
First Name & Middle Initial & Last Name & Degree
Burkert Pieske, MD
Facility Name
German Heart Center Berlin
City
Berlin
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Doris Pickel
Email
pickel@dhzb.de
First Name & Middle Initial & Last Name & Degree
Volkmar Falk, MD
Facility Name
University Hospital Bonn
City
Bonn
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sonja Friese
Email
sonja.friese@ukbonn.de
First Name & Middle Initial & Last Name & Degree
Farhad Bakhtiary
Facility Name
Medical Center Braunschweig
City
Braunschweig
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yessica Peglau
Email
j.peglau@klinikum-braunschweig.de
First Name & Middle Initial & Last Name & Degree
Wolfgang Harringer, MD
Facility Name
University Medical Center Frankfurt
City
Frankfurt
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Heike Strohschnitter
Email
Heike.Strohschnitter@kgu.de
First Name & Middle Initial & Last Name & Degree
Thomas Walther, MD
Facility Name
Heart Center, University of Freiburg
City
Freiburg
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Veronika Blümel, MD
Email
veronika.bluemel@universitaets-herzzentrum.de
First Name & Middle Initial & Last Name & Degree
Friedhelm Beyersdorf, MD
Facility Name
University Medical Center Heidelberg
City
Heidelberg
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christiane Miesel-Groeschel
First Name & Middle Initial & Last Name & Degree
Gábor Szabó, MD
Facility Name
University Medical Center Schleswig-Holstein Kiel
City
Kiel
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Beke Sarrahs
Email
beke.sarrahs@uksh.de
First Name & Middle Initial & Last Name & Degree
Assad Haneya, MD
Facility Name
University Medical Center Schleswig-Holstein Lübeck
City
Lübeck
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jessika Schmidt
Email
jessika.schmidt@uksh.de
First Name & Middle Initial & Last Name & Degree
Stefan Klotz, MD
Facility Name
German Heart Center Munich
City
Munich
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stephani Simon
Email
simons@dhm.mhn.de
First Name & Middle Initial & Last Name & Degree
Markus Krane, MD
Facility Name
Medical Center of the Ludwig-Maximilians-University Munich
City
Munich
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christian Hagl, MD
Email
christian.hagl@med.uni-muenchen.de
First Name & Middle Initial & Last Name & Degree
Christian Hagl, MD
Facility Name
University Hospitals Bristol NHS Foundation Trust
City
Bristol
ZIP/Postal Code
BS1 3NU
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emma Hopkins
Email
emma.hopkins@uhbristol.nhs.uk
First Name & Middle Initial & Last Name & Degree
Hunaid Vohra
Facility Name
Hull University Teaching Hospitals NHS Trust
City
Cottingham
ZIP/Postal Code
HU16 5JQ
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dumbor Ngaage
Email
dumbor.ngaage@nhs.net
Facility Name
South Tees Hospitals NHS Foundation Trust
City
Middlesbrough
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lynn Whitehouse
Email
lynn.whitehouse@nhs.net
First Name & Middle Initial & Last Name & Degree
Ralph White
Facility Name
Nottingham University Hospitals NHS Trust
City
Nottingham
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pamela Anderson
Email
pamela.anderson@nuh.nhs.uk
First Name & Middle Initial & Last Name & Degree
Anas Boulemden
Facility Name
Oxford University Hospitals NHS Foundation Trust
City
Oxford
ZIP/Postal Code
OX3 9DU
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
George Krasopoulos
Email
george.krasopoulos@ouh.nhs.uk
Facility Name
Sheffield Teaching Hospitals NHS Foundation Trust
City
Sheffield
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Helen Newell
Email
helen.newell2@nhs.net
First Name & Middle Initial & Last Name & Degree
Steven Hunter
Facility Name
University Hospitals Sussex NHS Foundation Trust
City
Worthing
ZIP/Postal Code
BN11 2DH
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dawn Martinez
Email
dawn.diokno@nhs.net
First Name & Middle Initial & Last Name & Degree
Istiaq M Ahmed

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
IPD Sharing Time Frame
OtherDe-identified study data sets must be submitted to the designated NHLBI Program Official no later than 3 years after the end of the clinical activity (final patient follow-up, etc.) or 2 years after the main paper of the trial has been published, whichever comes first. Data are prepared by the study coordinating center and sent to the designated PO for review prior to release.
IPD Sharing Access Criteria
Anyone who wishes to access the data.Any purpose.Data are available indefinitely at (Link to be included).
IPD Sharing URL
https://biolincc.nhlbi.nih.gov/studies/
Citations:
PubMed Identifier
33251914
Citation
Taha A, Nielsen SJ, Bergfeldt L, Ahlsson A, Friberg L, Bjorck S, Franzen S, Jeppsson A. New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Outcome: A Population-Based Nationwide Study From the SWEDEHEART Registry. J Am Heart Assoc. 2021 Jan 5;10(1):e017966. doi: 10.1161/JAHA.120.017966. Epub 2020 Nov 30.
Results Reference
derived
Links:
URL
http://www.ctsurgerynet.org/index.html
Description
The Cardiothoracic Surgical Trials Network

Learn more about this trial

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

We'll reach out to this number within 24 hrs